ABBOTT LABORATORIES (ABT) Debt Components
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $4.41B; Long-term Debt, Excluding Current MaturitiesUSD $29.64B; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $3.03B; Long-term Debt, Excluding Current MaturitiesUSD $9.90B; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $12.93B; Long-Term Debt, Maturity, Year OneUSD $3.00B.
- 2025-09-30: Long-term Debt, Current MaturitiesUSD $1.34B; Long-term Debt, Excluding Current MaturitiesUSD $11.60B; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
ABBOTT LABORATORIES Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD | Short-term Debt USD | Short-term Debt, Weighted Average Interest Rate, at Point in Time pure | Line of Credit Facility, Remaining Borrowing Capacity USD | Debt Instrument, Face Amount USD | Debt Instrument, Repurchase Amount USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $4.41B | $29.64B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $3.03B | $9.90B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | $12.93B | $3.00B | $700.00M | $653.00M | $591.00M | $650.00M | $7.40B | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $1.34B | $11.60B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $507.00M | $12.93B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $506.00M | $12.74B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $1.50B | $12.62B | $14.12B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | $1.50B | $2.90B | $617.00M | $650.00M | $583.00M | $8.00B | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $2.15B | $12.82B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $1.61B | $13.14B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $2.01B | $12.58B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $1.08B | $13.60B | $14.68B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | $1.10B | $1.50B | $3.00B | $656.00M | $651.00M | $8.00B | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $1.05B | $14.48B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $2.28B | $14.56B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $2.29B | $14.62B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $2.25B | $14.52B | $16.77B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | $2.30B | $1.10B | $1.50B | $2.90B | $600.00M | $8.70B | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $1.12B | $15.30B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $5.00M | $16.75B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $4.00M | $17.09B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2021-12-31 | $754.00M | $17.30B | $18.05B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | $754.00M | $2.30B | $1.20B | $1.50B | $3.00B | $9.30B | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $754.00M | $17.45B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $197.00M | (m) | (m) | (m) | (m) |
| 2021-06-30 | $755.00M | $17.55B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $199.00M | (m) | (m) | (m) | (m) |
| 2021-03-31 | $756.00M | $17.49B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $199.00M | (m) | (m) | (m) | (m) |
| 2020-12-31 | $7.00M | $18.53B | $18.53B | (m) | (m) | (m) | (m) | (m) | (m) | $213.00M | 0.40% | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | $7.00B | $753.00B | $2.40B | $1.30B | $1.50B | $12.50B | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $6.00M | $18.35B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $208.00M | (m) | (m) | (m) | (m) |
| 2020-06-30 | $1.29B | $18.18B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $205.00M | (m) | (m) | (m) | (m) |
| 2020-03-31 | $1.26B | $16.80B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $204.00M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 0.40% | (m) | (m) | (m) |
| 2019-12-31 | $1.28B | $16.66B | $17.94B | (m) | (m) | (m) | (m) | (m) | (m) | $201.00M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | $1.30B | $5.00B | $752.00M | $2.30B | $1.20B | $12.50B | (m) | (m) | $5.00B | (m) | (m) |
| 2019-09-30 | $1.25B | $17.64B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $204.00M | (m) | (m) | (m) | (m) |
| 2019-06-30 | $8.00M | $18.98B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $204.00M | (m) | (m) | (m) | (m) |
| 2019-03-31 | $8.00M | $18.84B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $201.00M | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 0.40% | (m) | (m) | (m) |
| 2018-12-31 | $7.00M | $19.36B | $19.37B | (m) | (m) | (m) | (m) | (m) | (m) | $200.00M | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | $7.00M | $1.80B | $2.90B | $750.00B | $2.30B | $11.80B | (m) | (m) | $5.00B | (m) | (m) |
| 2018-09-30 | $4.06B | $19.28B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $211.00M | (m) | (m) | (m) | (m) |
| 2018-06-30 | $506.00M | $19.82B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $341.00M | (m) | (m) | (m) | (m) |
| 2018-03-31 | $507.00M | $21.15B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $230.00M | (m) | (m) | (m) | (m) |
| 2018-01-05 | (m) | (m) | $1.15B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 0.30% | (m) | (m) | (m) |
| 2017-12-31 | $508.00M | $27.21B | $27.72B | (m) | (m) | (m) | (m) | (m) | (m) | $206.00M | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | $508.00M | $5.00B | $1.80B | $2.90B | $3.60B | $14.30B | (m) | (m) | $5.00B | (m) | (m) |
| 2017-09-30 | $504.00M | $23.31B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $211.00M | (m) | (m) | (m) | (m) |
| 2017-06-30 | $3.00M | $23.81B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $218.00M | (m) | (m) | (m) | (m) |
| 2017-03-31 | $3.00M | $23.76B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $207.00M | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 0.60% | (m) | (m) | (m) |
| 2016-12-31 | $3.00M | $20.68B | $20.68B | (m) | (m) | (m) | (m) | (m) | (m) | $1.32B | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | $3.00M | $2.00M | $3.80B | $1.30B | $2.90B | $12.90B | (m) | (m) | $5.00B | (m) | (m) |
| 2016-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $15.10B | (m) |
| 2016-09-30 | $4.00M | $5.97B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.53B | (m) | (m) | (m) | (m) |
| 2016-06-30 | $4.00M | $6.02B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.89B | (m) | (m) | (m) | (m) |
| 2016-03-31 | $3.00M | $5.98B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.61B | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 0.20% | (m) | (m) | (m) |
| 2015-12-31 | $3.00M | $5.87B | $5.87B | (m) | (m) | (m) | (m) | (m) | (m) | $3.13B | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | $3.00M | $2.00M | $1.00M | $900.00M | $1.30B | $3.50B | (m) | (m) | $5.00B | (m) | (m) |
| 2015-09-30 | $32.00M | $5.95B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.37B | (m) | (m) | (m) | (m) |
| 2015-06-30 | $32.00M | $5.86B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.87B | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.50B | (m) |
| 2015-03-31 | $51.00M | $5.93B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.92B | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 0.20% | (m) | (m) | (m) |
| 2014-12-31 | $55.00M | $3.39B | $3.45B | (m) | (m) | (m) | (m) | (m) | (m) | $4.38B | (m) | (m) | (m) | $500.00M |
| 2014-12-31 | (m) | (m) | (m) | $55.00M | $8.00M | $11.00M | $2.00M | $1.00B | $2.40B | (m) | (m) | $5.00B | (m) | (m) |
| 2014-09-30 | $206.00M | $3.72B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.38B | (m) | (m) | (m) | (m) |
| 2014-06-30 | $9.00M | $3.40B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.95B | (m) | (m) | (m) | (m) |
| 2014-03-31 | $8.00M | $3.39B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.37B | (m) | (m) | (m) | (m) |
| 2013-12-31 | $9.00M | $3.39B | $3.40B | (m) | (m) | (m) | (m) | (m) | (m) | $3.16B | 0.20% | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | $9.00M | $10.00M | $3.00M | $1.00M | $1.00M | $3.30B | (m) | (m) | $5.00B | (m) | (m) |
| 2013-09-30 | $264.01M | $3.40B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.60B | (m) | (m) | (m) | (m) |
| 2013-06-30 | $264.16M | $3.41B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.26B | (m) | (m) | (m) | (m) |
| 2013-03-31 | $277.60M | $3.47B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.36B | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 0.40% | (m) | (m) | $7.70B |
| 2012-12-31 | $309.00M | $18.09B | $18.39B | (m) | (m) | (m) | (m) | (m) | (m) | $2.08B | (m) | (m) | (m) | (m) |
| 2012-09-30 | $1.02B | $12.05B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.21B | (m) | (m) | (m) | (m) |
| 2012-06-30 | $1.02B | $12.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.06B | (m) | (m) | (m) | (m) |
| 2012-03-31 | $1.03B | $11.86B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.76B | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 0.40% | (m) | (m) | (m) |
| 2011-12-31 | $1.03B | $12.04B | $13.07B | (m) | (m) | (m) | (m) | (m) | (m) | $2.35B | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | $1.00B | $330.00M | $505.00M | $750.00M | $2.00B | $7.80B | (m) | (m) | $6.70B | (m) | (m) |
| 2011-09-30 | $35.00M | $13.10B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.59B | (m) | (m) | (m) | (m) |
| 2011-06-30 | $25.84M | $12.63B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.57B | (m) | (m) | (m) | (m) |
| 2011-03-31 | $1.53B | $12.53B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.72B | (m) | (m) | (m) | (m) |
| 2010-12-31 | $2.04B | $12.52B | $14.57B | (m) | (m) | (m) | (m) | (m) | (m) | $4.35B | 0.40% | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | $2.00B | $1.00B | $301.00M | $500.00M | $750.00M | $9.80B | (m) | (m) | $6.70B | (m) | (m) |
| 2010-09-30 | $2.22B | $12.91B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.59B | (m) | (m) | (m) | (m) |
| 2010-06-30 | $2.22B | $12.61B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.65B | (m) | (m) | (m) | (m) |
| 2010-03-31 | $718.09M | $10.88B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.73B | (m) | (m) | (m) | (m) |
| 2009-12-31 | $211.18M | $11.27B | $11.48B | (m) | (m) | (m) | (m) | (m) | (m) | $4.98B | 0.20% | (m) | (m) | (m) |
| 2009-09-30 | $35.11M | $11.58B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.04B | (m) | (m) | (m) | (m) |
| 2009-06-30 | $36.10M | $11.37B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.30B | (m) | (m) | (m) | (m) |
| 2008-12-31 | $1.04B | $8.71B | $9.75B | (m) | (m) | (m) | (m) | (m) | (m) | $1.69B | 0.50% | (m) | (m) | (m) |
| 2007-12-31 | $898.55M | $9.49B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.83B | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |